Filter
5938
Filtered Results: 5938
Text search:
medication
Featured
Recommendations
585
New Publications
1358
Language
Document type
No document type
3131
Studies & Reports
1002
Guidelines
807
Manuals
369
Strategic & Response Plan
182
Fact sheets
156
Training Material
141
Situation Updates
44
Brochures
39
Infographics
37
Resource Platforms
18
Online Courses
6
Videos
5
App
1
Countries / Regions
Global
272
India
253
South Africa
158
Kenya
152
Ethiopia
114
Western and Central Europe
112
Africa
99
Nigeria
93
Uganda
90
Sierra Leone
89
Nepal
88
Liberia
80
Ukraine
79
Tanzania
77
Zambia
77
Malawi
73
Ghana
71
Rwanda
65
Bangladesh
61
Latin America and the Carribbean
60
Syria
59
Myanmar / Burma
54
Germany
52
Philippines
49
Congo, Democratic Republic of
49
Namibia
43
South–East Asia Region
40
Eastern Europe
36
Zimbabwe
35
West and Central Africa
34
Lesotho
33
East and Southern Africa
32
Asia
31
Indonesia
31
Middle East and North Africa
29
South Sudan
28
Cambodia
26
Venezuela
26
Mozambique
25
Haiti
25
Russia
24
Burkina Faso
23
Guinea
22
Botswana
22
Cameroon
21
Eastern Europe and Central Asia
20
Yemen
19
Senegal
18
Brazil
17
Afghanistan
16
Jordan
16
Benin
15
Colombia
14
Thailand
14
USA
14
Western Pacific Region
14
Lebanon
14
Vietnam
14
Pakistan
14
Eswatini/ Swaziland
13
Tajikistan
12
Sudan
12
Central African Republic
12
Laos
10
Argentina
10
China
9
Albania
9
Moldova
9
Somalia
9
Paraguay
8
Sri Lanka
8
Mali
8
Chile
7
Peru
7
Palestine
7
Georgia
7
Iraq
7
Madagascar
7
Iran
6
Côte d’Ivoire / Ivory Coast
6
Mexico
5
Serbia
5
Kyrgyzstan
5
North America
5
United Kingdom
5
Papua New Guinea
5
Libya
5
Ecuador
5
North Macedonia
4
Kazakhstan
4
Canada
4
Morocco
4
Jamaica
4
Spain
4
Southern Africa
4
Bolivia
4
Chad
4
Bhutan
4
Timor Leste/ East Timor
3
Turkey
3
Estonia
3
Niger
3
Burundi
3
Malaysia
3
Guinea-Bissau
3
Saudi Arabia
3
Japan
3
Egypt
3
Romania
3
Angola
3
Guatemala
3
Gambia
2
Togo
2
Fiji
2
Mongolia
2
Bulgaria
2
Armenia
2
Hungary
2
Lithuania
2
Turkmenistan
2
Tunisia
2
Portugal
2
Azerbaijan
2
Belarus
2
Djibouti
2
Greece
2
Poland
2
North Korea
1
Switzerland
1
El Salvador
1
Australia
1
Singapore
1
Uzbekistan
1
Qatar
1
Croatia
1
Ireland
1
Gabon
1
Denmark
1
Mauritius
1
Norway
1
South Korea
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Slovakia
1
Solomon Islands
1
Bahamas
1
Authors & Publishers
Publication Years
Category
Countries
1944
Clinical Guidelines
576
Public Health
411
Women & Child Health
325
Key Resources
184
Capacity Building
167
Pharmacy & Technologies
56
Annual Report MEDBOX
2
Toolboxes
Mental Health
728
HIV
463
COVID-19
443
TB
335
Caregiver
253
NCDs
242
Disability
202
AMR
199
Refugee
186
Conflict
155
Planetary Health
143
Pharmacy
139
NTDs
139
Ebola
129
Rapid Response
128
Global Health Education
76
Natural Hazards
46
Social Ethics
30
Zika
27
Specific Hazards
22
Health Financing Toolbox
22
Polio
21
Cholera
19
South Sudan
1
Health Financing
1
Typhoon
1
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo...
The survey highlights changes that have taken place in Bangladesh’s demographic and health situation since the previous BDHS surveys. The survey provides important information for policymakers and program personnel in addressing the monitoring and evaluation needs of the 4th Health, Population and...
To improve the quality of care during labour and childbirth, facilitate effective implementation of the World Health Organization (WHO) recommendations: Intrapartum care for a positive childbirth experience, published in 2018, and promote a shift towards improving the experience of childbirth, WHO d...
Conflict
In early October, Ukrainian forces continued recapturing areas of southern and eastern oblasts, notably Lyman (Donetsk oblast). The liberation of thousands of square kilometres resulted in the grim discovery of two new mass graves in Lyman and Sviatohirsk (containing of 120 civilian bodi...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Schistosoma haematobium is a parasitic digenetic trematode responsible for schistosomiasis (also known as bilharzia). The disease is caused by penetration of the skin by the parasite, spread by intermediate host molluscs in stagnant waters, and can be treated by administration of praziquantel. Schis...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
Several Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Nether...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully controlled by the Government of Ukraine, and for peop...
Background: One of the objectives of the Global Action Plan by the World Health Organization (WHO) to contain antimicrobial resistance (AMR), is to improve global awareness through effective communication and education. Comprehensive information on the level of awareness of AMR among Nigerian public...
Glaucoma is a leading cause of irreversible blindness globally. In Malawi, glaucoma accounts for 15.8% of the blindness among people aged 50 years and above. Blindness from glaucoma is preventable with early detection and timely treatment. However, glaucoma management remains a challenge to eye care...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
